Literature DB >> 22018269

Centrosomal dysregulation in human metastatic melanoma cell lines.

Geoffrey A Charters1, Clare J Stones, Andrew N Shelling, Bruce C Baguley, Graeme J Finlay.   

Abstract

Correct partitioning of the replicated genome during mitosis is orchestrated by centrosomes, and chromosomal instability is a commonly reported feature of human cancer. Melanomas are notorious for their genetic instability and rapid clonal evolution that may be manifested as aggressive growth and facile generation of therapy-resistant variants. We characterized the centrosomal status, ploidy, and gene status (TP53, CDKN2A/B, BRAF, and NRAS) of 15 human metastatic melanoma cell lines. Cells were labelled for pericentrin (a centrosomal marker), DNA and α-tubulin, and scored for centrosome morphology, supernumerary centrosomes, and mitotic symmetry. The incidence of supernumerary centrosomes correlated with that of gross centrosomal abnormalities (r = 0.90), mitotic asymmetry (r = 0.90), and, surprisingly, increased content of G/M cells (r = 0.79). Centrosomal numerical dysregulation, observed in all cell lines, was found not to be specifically related to the status of any of the characterized gene mutations that were found in 13/15 cell lines. We conclude that centrosomal dysregulation may arise from multiple mechanisms and may drive the generation of genetic and phenotypic diversity in melanoma.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22018269     DOI: 10.1016/j.cancergen.2011.07.001

Source DB:  PubMed          Journal:  Cancer Genet


  13 in total

1.  NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation.

Authors:  Jiatian Lin; Xiangling Chen; Hongjian Yu; Shasha Min; Yequn Chen; Zesong Li; Xina Xie
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

2.  Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma.

Authors:  Ryan A Denu; Maria Shabbir; Minakshi Nihal; Chandra K Singh; B Jack Longley; Mark E Burkard; Nihal Ahmad
Journal:  Mol Cancer Res       Date:  2018-01-12       Impact factor: 5.852

3.  An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.

Authors:  Geetika Sethi; Harsh B Pathak; Hong Zhang; Yan Zhou; Margret B Einarson; Vinod Vathipadiekal; Sumedha Gunewardena; Michael J Birrer; Andrew K Godwin
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

4.  Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines.

Authors:  Ji Eun Kim; Clare Stones; Wayne R Joseph; Euphemia Leung; Graeme J Finlay; Andrew N Shelling; Wayne A Phillips; Peter R Shepherd; Bruce C Baguley
Journal:  BMC Cancer       Date:  2012-04-04       Impact factor: 4.430

5.  Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.

Authors:  Clare J Stones; Ji Eun Kim; Wayne R Joseph; Euphemia Leung; Elaine S Marshall; Graeme J Finlay; Andrew N Shelling; Bruce C Baguley
Journal:  Front Genet       Date:  2013-05-08       Impact factor: 4.599

6.  siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo.

Authors:  Peng Hu; Xi Chen; Jing Sun; Ping Bie; Lei-Da Zhang
Journal:  Biosci Rep       Date:  2015-01-14       Impact factor: 3.840

7.  Increased SPC24 in prostatic diseases and diagnostic value of SPC24 and its interacting partners in prostate cancer.

Authors:  Suixia Chen; Xiao Wang; Shengfeng Zheng; Hongwen Li; Shouxu Qin; Jiayi Liu; Wenxian Jia; Mengnan Shao; Yanjun Tan; Hui Liang; Weiru Song; Shaoming Lu; Chengwu Liu; Xiaoli Yang
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

8.  Pericentrin in health and disease: Exploring the patchwork of Pericentrin splice variants.

Authors:  Johanna Mühlhans; Andreas Gießl
Journal:  Commun Integr Biol       Date:  2012-07-01

9.  Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines.

Authors:  Ji Eun Kim; Euphemia Leung; Bruce C Baguley; Graeme J Finlay
Journal:  Front Genet       Date:  2013-05-31       Impact factor: 4.599

10.  The role of the hippo pathway in melanocytes and melanoma.

Authors:  Ji Eun Kim; Graeme J Finlay; Bruce C Baguley
Journal:  Front Oncol       Date:  2013-05-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.